The supplementation of curcumin encapsulated within fenugreek mucilage has shown to improve cognitive and locomotive function of patients suffering from mild dementia, according to a six-month-long RCT conducted in India.
Supplementation with a highly bioavailable curcumin formulation may improve knee joint health and mobility in people with mild osteoarthritis, says a new multi-centric, randomized, double-blind, parallel, placebo-controlled study.
A new review has identified omega-3 fatty acids and red yeast rice to have the strongest potential for use within nutraceuticals to target inflammation, due to strong data obtained from multiple randomised controlled trials (RCTs).
A new study observes a significant increase in skull bone repair in rat models of critical bone defects, following the repeated daily administration of pigenin, curcumin, and resveratrol, with apigenin found to induce the most consistent results.
“Consumers’ perception of curcumin supplements has evolved from accepting, to apprehensive” due to highly publicised liver damage cases but this will be good for the industry in the long-run, according to an industry expert.
Outpatients who were administered curcumin (CUR) and quercetin (QUE) after testing positive for early-stage SARS-CoV-2 were found to clear the virus at a significantly faster rate, compared to those receiving standard of care (SOC) alone.
Curcumin supplementation is more effective than coenzyme Q10 in reducing cholesterol levels, but the combination of both had no effect on body composition, hypertension, and glycaemic control, according to a new RCT.
A new paper reports a small number of cases of liver injury associated with turmeric supplements, but independent experts tell us that any such phenomena appear to be “rare”, and noted that the botanical has a low risk profile.
Düsseldorf-based Cellavent Ingredients has announced the launch of a turmeric ingredient produced by three Lactobacillus strains that is said to offer the benefits of the botanical plus postbiotics and paraprobiotics.
The Italian Ministry of Health has acted on recent adverse events linked to turmeric-based food supplements by prohibiting all health claims linked to the botanical, and issuing a new warning to be used on product labels.
Concerns that restrictions may be coming about turmeric-containing food supplements may be premature, but the issue could have “wider ramifications for the industry”, leading regulatory experts tell NutraIngredients.
OmniActive Health Technologies’ new Curcuwin Ultra+ ingredient, launched last fall in the US, is effective at boosting curcuminoid levels in the body at a “considerably smaller dose” than standard curcumin.
More than 40% of curcumin supplements purchased online and from health food shops in France failed to match label claims, a report has found, shining a spotlight on quality control issues within the industry.
By Traci Kantowski, Communications Director, Global Curcumin Association
When asked to write this article, the Simple Minds song “Don’t You forget about me” immediately popped in my head. While it’s no longer the exciting new kid on the block, curcumin is the “friend” the industry needs.
Twelve weeks of supplementation with a turmeric extract led to significant reductions in body weight for overweight but healthy people. The extract was also associated with improvements in mental health scores.
Supplementation with curcumin may protect against muscle damage and enhance performance after acute physical exercise for sedentary individuals, says a new systematic review of the data that supports the effects observed in athletic adults.
The supplementation of both omega-3 and nanocurcumin could decrease the incidence and severity of episodic migraine by reducing the genetic expression of a particular molecule in the body, based on the findings of a two-month RCT.
A new review concludes there is strong evidence for how curcuminoids can support vascular health. But the authors note that much of that evidence comes from in vitro tests and trials using animal models.
Curcumin from the branded curcumin-fenugreek complex, CurQfen, may be delivered to the hippocampus of the brain and improve locomotor activity and spatial memory, says a new pharmacokinetic study with rats.
A curcumin-fenugreek complex (CurQfen) may produce greater improvements in joint pain, stiffness, and physical functions in people with osteoarthritis compared to glucosamine-chondroitin, says a new study from India.